[{"address1": "2265 Upper Middle Road East", "address2": "Suite 602", "city": "Oakville", "state": "ON", "zip": "L6H 0G5", "country": "Canada", "phone": "289 910 0850", "fax": "905 481 2394", "website": "https://www.cardiolrx.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. David G. Elsley MBA", "title": "President, CEO & Director", "fiscalYear": 2023, "totalPay": 527044, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher J. Waddick C.A., C.M.A., CPA, CMA, MBA", "title": "CFO, Corporate Secretary & Director", "fiscalYear": 2023, "totalPay": 207690, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bernard  Lim B.Sc.", "title": "Chief Operating Officer", "fiscalYear": 2023, "totalPay": 363457, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew Warwick Hamer M.D.", "age": 62, "title": "Chief Medical Officer & Head of Research & Development", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 525961, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Trevor  Burns", "title": "Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John A. Geddes BSCPT, MBA", "title": "Vice President of Corporate Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.24, "open": 1.25, "dayLow": 1.19, "dayHigh": 1.25, "regularMarketPreviousClose": 1.24, "regularMarketOpen": 1.25, "regularMarketDayLow": 1.19, "regularMarketDayHigh": 1.25, "beta": 0.665, "forwardPE": -3.2105265, "volume": 292693, "regularMarketVolume": 292693, "averageVolume": 343020, "averageVolume10days": 226510, "averageDailyVolume10Day": 226510, "bid": 1.17, "ask": 1.25, "bidSize": 100, "askSize": 100, "marketCap": 99556152, "fiftyTwoWeekLow": 1.17, "fiftyTwoWeekHigh": 3.12, "fiftyDayAverage": 1.3502, "twoHundredDayAverage": 1.88175, "currency": "USD", "enterpriseValue": 83837144, "floatShares": 77722363, "sharesOutstanding": 81603400, "sharesShort": 1434366, "sharesShortPriorMonth": 1322872, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0176, "heldPercentInsiders": 0.04003, "heldPercentInstitutions": 0.11228, "shortRatio": 5.4, "shortPercentOfFloat": 0.0183, "impliedSharesOutstanding": 81844000, "bookValue": 0.149, "priceToBook": 8.18792, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -36136008, "trailingEps": -0.38, "forwardEps": -0.31, "enterpriseToEbitda": -2.196, "52WeekChange": -0.25748503, "SandP52WeekChange": 0.22903383, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "CRDL", "underlyingSymbol": "CRDL", "shortName": "Cardiol Therapeutics Inc.", "longName": "Cardiol Therapeutics Inc.", "firstTradeDateEpochUtc": 1547562600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "ee9d962b-eed4-3063-8df9-c815990fe5d8", "messageBoardId": "finmb_424954803", "gmtOffSetMilliseconds": -18000000, "currentPrice": 1.22, "targetHighPrice": 9.906213, "targetLowPrice": 7.9007125, "targetMeanPrice": 8.81514, "targetMedianPrice": 8.726817, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 15885018, "totalCashPerShare": 0.195, "ebitda": -38172776, "totalDebt": 165984, "quickRatio": 2.323, "currentRatio": 2.485, "debtToEquity": 1.591, "returnOnAssets": -0.7907, "returnOnEquity": -1.59533, "freeCashflow": -12152216, "operatingCashflow": -25932334, "financialCurrency": "CAD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]